USAID has recently confirmed that the fiscal year (FY) 2011 funding level for USAID’s NTD Program will be $77 million. This figure, although below the President’s original FY11 request of $155 million, is a $12 million increase from the program’s FY10 allocation of $65 million. The United States has now collectively appropriated $212 million over a six-year period toward NTD control and elimination programs, building on the generous drug donations from the pharmaceutical industry. It is unknown what FY12 will bring under the new debt ceiling agreement and whether or not this funding level can be maintained; however, given the current economic climate, it is a huge win in the fight against NTDs!
Addressing NTDs, which began in FY06, is an objective within the click here.